Michael P Hay

14PUBLICATIONS
27CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHuman impacts of climate change and human adaptationBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 23, 2024
Novel Prodrug Strategies for the Treatment of Tuberculosis.

Christine G Kim, Jiney Jose, Michael P Hay

|Aug 14, 2024
Megakaryocyte maturation involves activation of the adaptive unfolded protein response.

Mifra Faiz, Maggie L Kalev-Zylinska, Caitlin Dunstan-Harrison

|Jul 15, 2024
Identification of 6-Anilino Imidazo[4,5-<i>c</i>]pyridin-2-ones as Selective DNA-Dependent Protein Kinase Inhibitors and Their Application as Radiosensitizers.

Cho R Hong, Lydia P Liew, Way W Wong

|Jul 24, 2023
Hypoxia-activated prodrugs of phenolic olaparib analogues for tumour-selective chemosensitisation.

Way W Wong, Sophia F O'Brien-Gortner, Robert F Anderson

|Jun 10, 2023
Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers.

Lydia P Liew, Avik Shome, Way W Wong

|Feb 15, 2022
Spin Trapping Hydroxyl and Aryl Radicals of One-Electron Reduced Anticancer Benzotriazine 1,4-Dioxides.

Wen Qi, Pooja Yadav, Cho R Hong

Pageof 3

Frequent Collaborators

5 joint publications

Benjamin D Dickson

4 joint publications

Stephen M F Jamieson

3 joint publications

Robert F Anderson

2 joint publications

Lydia P Liew